Search research articles
Contact Us
Filters
Showing results (461-470 of 1,408) with videos related to
Page
of 141
Sort By:
Blood
|
January 25, 2002
Acute promyelocytic leukemia: evolving therapeutic strategies
Martin S Tallman, Chadi Nabhan, James H Feusner, et al.
Cancer Immunology, Immunotherapy : CII
|
January 18, 2012
Rituximab-induced direct inhibition of T-cell activation
Dina Stroopinsky, Tamar Katz, Jacob M Rowe, et al.
Hematology. American Society of Hematology. Education Program
|
November 28, 2001
Acute myeloid leukemia
F R Appelbaum, J M Rowe, J Radich, et al.
International Journal of Cancer
|
April 15, 1982
Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity
M Rowe, J E Hildreth, A B Rickinson, et al.
Nature
|
June 3, 1982
Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen
L E Wallace, A B Rickinson, M Rowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2023
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
Susan DeWolf, Martin S Tallman, Jacob M Rowe, et al.
The Journal of Biological Chemistry
|
April 27, 2001
A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family
A Ghosh, S N Sarkar, T M Rowe, et al.
Bone Marrow Transplantation
|
March 30, 2010
Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT
R Elhasid, N Krivoy, J M Rowe, et al.
European Journal of Immunology
|
July 28, 2009
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity
Dina Stroopinsky, Irit Avivi, Jacob M Rowe, et al.
The Journal of Experimental Medicine
|
November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes
C C Delibrias, J E Floettmann, M Rowe, et al.
Page
of 141
Search research articles
Search
Showing results (461-470 of 1,408) with videos related to
Sort By:
Page
of 141
Blood
|
January 25, 2002
Acute promyelocytic leukemia: evolving therapeutic strategies
Martin S Tallman, Chadi Nabhan, James H Feusner, et al.
Cancer Immunology, Immunotherapy : CII
|
January 18, 2012
Rituximab-induced direct inhibition of T-cell activation
Dina Stroopinsky, Tamar Katz, Jacob M Rowe, et al.
Hematology. American Society of Hematology. Education Program
|
November 28, 2001
Acute myeloid leukemia
F R Appelbaum, J M Rowe, J Radich, et al.
International Journal of Cancer
|
April 15, 1982
Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity
M Rowe, J E Hildreth, A B Rickinson, et al.
Nature
|
June 3, 1982
Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen
L E Wallace, A B Rickinson, M Rowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2023
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
Susan DeWolf, Martin S Tallman, Jacob M Rowe, et al.
The Journal of Biological Chemistry
|
April 27, 2001
A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family
A Ghosh, S N Sarkar, T M Rowe, et al.
Bone Marrow Transplantation
|
March 30, 2010
Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT
R Elhasid, N Krivoy, J M Rowe, et al.
European Journal of Immunology
|
July 28, 2009
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity
Dina Stroopinsky, Irit Avivi, Jacob M Rowe, et al.
The Journal of Experimental Medicine
|
November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes
C C Delibrias, J E Floettmann, M Rowe, et al.
Page
of 141